학술논문
A phase IIb, open-label, randomized controlled dose ranging multi-centre trial to evaluate the safety, tolerability, pharmacokinetics and exposure-response relationship of different doses of delpazolid in combination with bedaquiline delamanid moxifloxacin in adult subjects with newly diagnosed, uncomplicated, smear-positive, drug-sensitive pulmonary tuberculosis
Document Type
Article
Author
Dierig, A.; Hoelscher, M.; Schultz, S.; Hoffmann, L.; Jarchow-MacDonald, A.; Heinrich, N.; Svensson, E.; Te Brake, L.; Aarnoutse, R.; Boeree, M.; McHugh, T.; Wildner, L.; Gong, X.; Phillips, P.; Minja, L.; Ntinginya, N.; Mpagama, S.; Liyoyo, A.; Wallis, R.; Sebe, M.; Mhimbira, F.; Mbeya, B.; Rassool, M.; Geiter, L.; Cho, Y.
Source
In: Trials . (Trials, December 2023, 24(1))
Subject
Language
English
ISSN
17456215